About Avrobio (AVRO)
AVROBIO, Inc. is a clinical-stage gene therapy company. The Company is focused on developing curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. Its gene therapies employ he... Read more
- USD1.55
- USD1.57
- USD1.53
- USD1.93
- 0.70%
- --
- 153.34k
- 327.51k
- 68M
- 0.56
- 128.70%
- 3.80%
Stock News
yesterday
: Government shutdown: Video reportedly shows Rep. Jamaal Bowman pulling fire alarm as House scrambles to vote on spending bill
MarketWatch
yesterday
Commodities Corner: Why gasoline prices are set to fall even as oil marches toward $100 a barrel
MarketWatch
yesterday
Living With Climate Change: Here’s how El Niño will impact winter, including skiing and snowboarding plans
MarketWatch
yesterday
These are the top 4 Club stocks — and the bottom 4 — during the third quarter
CNBC
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
